Drug Type Small molecule drug |
Synonyms L-leucine/metformin, Leucine/metformin, Metformin/L-leucine + [1] |
Target |
Action activators |
Mechanism PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC6H13NO2 |
InChIKeyROHFNLRQFUQHCH-YFKPBYRVSA-N |
CAS Registry61-90-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | United States | 01 Aug 2014 |